Cargando…

Altered glutamine metabolism in platinum resistant ovarian cancer

Ovarian cancer is characterized by an increase in cellular energy metabolism, which is predominantly satisfied by glucose and glutamine. Targeting metabolic pathways is an attractive approach to enhance the therapeutic effectiveness and to potentially overcome drug resistance in ovarian cancer. In p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hudson, Chantelle D., Savadelis, Alyssa, Nagaraj, Anil Belur, Joseph, Peronne, Avril, Stefanie, DiFeo, Analisa, Avril, Norbert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173084/ https://www.ncbi.nlm.nih.gov/pubmed/27191653 http://dx.doi.org/10.18632/oncotarget.9317

Ejemplares similares

Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance
por: Nagaraj, Anil Belur, et al.
Publicado: (2015)

miR-181a modulates circadian rhythm in immortalized bone marrow and adipose derived stromal cells and promotes differentiation through the regulation of PER3
por: Knarr, Matthew, et al.
Publicado: (2019)

Cisplatin induces stemness in ovarian cancer
por: Wiechert, Andrew, et al.
Publicado: (2016)

A miRNA-Mediated Approach to Dissect the Complexity of Tumor-Initiating Cell Function and Identify miRNA-Targeting Drugs
por: Belur Nagaraj, Anil, et al.
Publicado: (2019)

Detection of Tumor-Specific PTPmu in Gynecological Cancer and Patient Derived Xenografts
por: Vincent, Jason, et al.
Publicado: (2021)

The Molecular ‘Myc-anisms’ Behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics
por: McAnulty, Jessica, et al.
Publicado: (2020)

Crowdsourcing Awareness: Exploration of the Ovarian Cancer Knowledge Gap through Amazon Mechanical Turk
por: Carter, Rebecca R., et al.
Publicado: (2014)

miR-181a initiates and perpetuates oncogenic transformation through the regulation of innate immune signaling
por: Knarr, Matthew, et al.
Publicado: (2020)

InFlo: a novel systems biology framework identifies cAMP-CREB1 axis as a key modulator of platinum resistance in ovarian cancer
por: Dimitrova, N, et al.
Publicado: (2017)

microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial–mesenchymal transition
por: Parikh, Aditya, et al.
Publicado: (2014)

Nucleo-Cytoplasmic Localization Domains Regulate Krüppel-Like Factor 6 (KLF6) Protein Stability and Tumor Suppressor Function
por: Rodríguez, Estefanía, et al.
Publicado: (2010)

New ways of assessing ovarian cancer response: metabolic imaging and beyond
por: Rockall, Andrea, et al.
Publicado: (2012)

Increased PDGFR-beta and VEGFR-2 protein levels are associated with resistance to platinum-based chemotherapy and adverse outcome of ovarian cancer patients
por: Avril, Stefanie, et al.
Publicado: (2017)

Ovarian Cancer and Glutamine Metabolism
por: Fasoulakis, Zacharias, et al.
Publicado: (2023)

Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria
por: Hauptmann, Steffen, et al.
Publicado: (2016)

STING pathway expression in low‐grade serous carcinoma of the ovary: an unexpected therapeutic opportunity?
por: Huvila, Jutta, et al.
Publicado: (2021)

CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors
por: Saygin, Caner, et al.
Publicado: (2017)

Resistance to the tyrosine kinase inhibitor axitinib is associated with increased glucose metabolism in pancreatic adenocarcinoma
por: Hudson, C D, et al.
Publicado: (2014)

MiR-181a targets STING to drive PARP inhibitor resistance in BRCA- mutated triple-negative breast cancer and ovarian cancer
por: Bustos, Matias A., et al.
Publicado: (2023)

Splicing factor proline- and glutamine-rich (SFPQ) protein regulates platinum response in ovarian cancer-modulating SRSF2 activity
por: Pellarin, Ilenia, et al.
Publicado: (2020)

Multiple Breast Cancer Cell-Lines Derived from a Single Tumor Differ in Their Molecular Characteristics and Tumorigenic Potential
por: Mosoyan, Goar, et al.
Publicado: (2013)

Targeting glutamine metabolism enhances responses to platinum-based chemotherapy in triple-negative breast cancers (TNBC)
por: Hong, Jiaxin, et al.
Publicado: (2022)

Penicillin induces alterations in glutamine metabolism in Streptococcus pneumoniae
por: El Khoury, Jessica Y., et al.
Publicado: (2017)

Preparing for adulthood: thousands upon thousands of new cells are born in the hippocampus during puberty, and most survive with effortful learning
por: Curlik, Daniel M., et al.
Publicado: (2014)

The continuity supervisor
por: Rowlands, Avril, et al.
Publicado: (2000)

Variation in Cell Signaling Protein Expression May Introduce Sampling Bias in Primary Epithelial Ovarian Cancer
por: Mittermeyer, Gabriele, et al.
Publicado: (2013)

Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer
por: Yang, Lifeng, et al.
Publicado: (2014)

Reprogramming of glutamine metabolism via glutamine synthetase silencing induces cisplatin resistance in A2780 ovarian cancer cells
por: Guo, Jing, et al.
Publicado: (2021)

Small-Molecule–Mediated Stabilization of PP2A Modulates the Homologous Recombination Pathway and Potentiates DNA Damage-Induced Cell Death
por: Avelar, Rita A., et al.
Publicado: (2023)

Patient perceptions and understanding of treatment instructions for ovarian stimulation during infertility treatment
por: Barrière, Paul, et al.
Publicado: (2019)

Contributions of the Epidermal Growth Factor Receptor to Acquisition of Platinum Resistance in Ovarian Cancer Cells
por: Granados, Michaela L., et al.
Publicado: (2015)

Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment
por: Nagaraj, A B, et al.
Publicado: (2018)

Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy
por: Uno, Kaname, et al.
Publicado: (2022)

Mistletoe Extract Viscum Fraxini-2 for Treatment of Advanced Hepatocellular Carcinoma: A Case Series
por: Lee, Richard T., et al.
Publicado: (2021)

Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer
por: Ni, Rui, et al.
Publicado: (2023)

ADAM17 inhibition enhances platinum efficiency in ovarian cancer
por: Hedemann, Nina, et al.
Publicado: (2018)

RB in glutamine metabolism
por: Clem, Brian
Publicado: (2014)

An analytical study of neocartilage from microtia and otoplasty surgical remnants: A possible application for BMP7 in microtia development and regeneration
por: Childs, Robin DiFeo, et al.
Publicado: (2020)

Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer
por: Sassu, Carolina Maria, et al.
Publicado: (2021)

Jazz : an introduction to its musical basis
por: Dankworth, Avril
Publicado: (1968)

Cannot write session to /tmp/vufind_sessions/sess_43ai4tk89cmb3h5i4lmb4o0i96